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Abstract
Methods to identify signatures of selective sweeps in population genomics data have been actively 
developed, but mostly do not identify the specific mutation favored by selection. We present a 
method, iSAFE, that uses a statistic derived solely from population genetics signals to accurately 
pinpoint the favored mutation in a large region (~5 Mbp). iSAFE does not require any knowledge 
of demography, specific phenotype under selection, or functional annotations of mutations.
Human genetic data have revealed a multitude of genomic regions believed to be evolving 
under positive selection. Methods for detecting regions under selection from genetic 
variations exploit a variety of genomic signatures. Allele frequency based methods analyze 
the distortion in site frequency spectrums; Linkage Disequilibrium (LD) based methods use 
extended homozygosity in haplotypes; other methods use differences in allele frequency 
between populations; and finally, composite methods combine multiple test scores to 
improve the resolution1–3. Recently, a lack of rare (singleton) mutations has been used to 
detect very recent selection4. The signature of a selective sweep can be captured even when 
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
Correspondence should be addressed to A.A.(alakbari@ucsd.edu) or V.B. (vbafna@ucsd.edu).
Author contributions. A.A., S.M., and V.B. conceived and designed the experiments and wrote the manuscript with input from all 
authors; A.A., J.J.V., and A.I. performed the experiments; A.A. analyzed the data. A.A. and M.B. developed software tools; P.C.S., 
S.M., and V.B. provided guidance throughout the study.
Competing financial interests. V.B. is a co-founder, has an equity interest, and receives income from Digital Proteomics, LLC. The 
terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict 
of interest policies. D.P. was not involved in the research presented here.
Code availability. The iSAFE software and the instruction are available at https://github.com/alek0991/iSAFE and as Supplementary 
Software.
Data availablity. For all the following datasets, the genome build is GRCh37/hg19. We downloaded the phased haplotypes of the 
1000GP9 (phase 3) dataset from http://ftp.1000genomes.ebi.ac.uk/vol1/ftp/ release/20130502 /. The ancestral allele dataset from 
Ensembl39 (release 75) is downloaded from http://ftp.ensembl.org/pub/release-75/fasta/ancestral_alleles/. The physical position was 
converted into genetic position using the HapMap II40 genetic map downloaded from http://ftp-trace.ncbi.nih.gov/1000genomes/ftp/
technical/working/20110106_recombination_hotspots/. A Life Sciences Reporting Summary is available.
HHS Public Access
Author manuscript
Nat Methods. Author manuscript; available in PMC 2018 November 12.
Published in final edited form as:
Nat Methods. 2018 April ; 15(4): 279–282. doi:10.1038/nmeth.4606.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
standing variation or multiple de novo mutations create a ‘soft’ sweep of distinct haplotypes 
carrying the favored mutation. Paired with deep sequencing data, these methods have 
identified multiple regions believed to be under selection, and provide a window into genetic 
adaptation and evolution.
In contrast, little work has been done to identify the favored mutation in a selective sweep. 
Grossman et al.5 note that different selection signals identify overlapping but different 
regions, and a composite of multiple signals (CMS) can localize the site of the favored 
mutation. An alternative strategy is to use rank SNPs based on their functional annotations. 
However, the signal of selection is often spread over regions up to 1–2 Mbp on either side3, 
and the high LD makes it difficult to pinpoint the favored mutation. Here, we propose a 
method, iSAFE (integrated Selection of Allele Favored by Evolution), that exploits 
coalescent-based signals in ‘shoulders’3 of the selective sweep (genomic regions proximal to 
the region under selection, but carrying the selection signal) to rank all mutations within a 
large (5 Mbp) region based on their contribution to the selection signal.
Haplotype Allele Frequency (HAF) score is a haplotypic score that aims to separate carrier 
haplotypes from non-carriers without knowing the favored mutation6. Based on properties of 
the HAF-score, we develop a SAFE-score (see Online Methods and Supplementary Note 1; 
Fig. 1a,b and Supplementary Fig. 1) that tends to be maximized for the favored mutation in a 
small region (50 kbp), but the performance decays when larger regions are investigated. To 
address the more general case of large regions (~5 Mbp) under selection, we developed the 
iSAFE-score, which uses a 2-step procedure to identify the favored variant. In the first step, 
it finds the best candidate mutations in small (low recombination) windows using the SAFE-
score. Then, it combines SAFE-scores of all variants over all windows to give an iSAFE-
score to each variant in the large region (see Online Methods and Supplementary Note 1; 
Fig. 2a,b).
The main alternatives to iSAFE are Composite of Multiple Signals (CMS)5, and Selection 
detection by Conditional Coalescent Tree (SCCT)7. CMS combines statistics from different 
selection tests, including the integrated Haplotype Score (iHS)8, so as to localize the signal. 
In order to develop a unified probabilistic model, CMS expects control populations as input, 
as well as demographic models, and cannot be run using only the SNP matrix. Therefore, we 
first compared SAFE against iHS and SCCT in simulations. The median SAFE rank of the 
favored mutation in a 50 kbp region was 1 out of ∼250 variants (Fig. 1c, left), and the 
favored mutation ranked among the top 5 in 91% of simulations. In comparison, the median 
ranks of iHS and SCCT were 6 and 3, respectively. The SAFE-score performance remained 
robust to a large range of parameter choices (Supplementary Fig. 2). However, in testing 
with increasing window sizes, we observed that the median rank increases beyond 80 kbp, 
perhaps because of the confounding signal at the shoulders of the selective sweep (Fig. 2c).
iSAFE, unlike SAFE, is specifically designed to exploit signal from the shoulders of the 
sweep (see Online Methods and Fig. 2a,b). iSAFE showed consistently high performance as 
the window size was increased from 250 kbp all the way to 5 Mbp (Fig. 2c). The median 
rank remained between 3 and 5 up to 5 Mbp, and the performance remained robust to a large 
range of parameter choices (Supplementary Fig. 3–6). iSAFE greatly improved upon iHS 
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and SCCT, placing the favored mutation within top 20 in 88% of the cases, in contrast to 
iHS (39%), and SCCT (34%), for an ongoing selective sweep with fixed population size 
(Supplementary Fig. 3).
Not surprisingly, iSAFE performance deteriorates when the favored mutation is fixed, or 
near fixation (favored allele frequency (ν) > 0.9 in Supplementary Fig. 3). To handle this 
special case, we include individuals from non-target populations using a specific protocol 
(see Online Methods). Subsequently, the performance remained unchanged for ν < 0.9 and 
dramatically improved for high frequencies, including when the favored mutation was fixed 
in the target population (Supplementary Fig. 3). We also tested iSAFE against CMS using a 
model of human demography. While CMS showed excellent performance in localizing the 
favored mutation, iSAFE scoring greatly improved the ranking. For example, iSAFE ranked 
the favored mutation within the top 20 in 94% of the simulations of a 5 Mbp region (Fig. 3a 
and Supplementary Fig. 4), in contrast to CMS, which had a top 20 ranking in 35% of cases.
iSAFE-scores are not based upon likelihood computations, and we use them primarily to 
rank order the mutations. However, iSAFE-scores are normalized and can be compared 
across samples. Empirically computed P values (see Online Methods) on iSAFE indicate 
good performance when P < 1e-4, (iSAFE ≥ 0.1; Supplementary Fig. 7).
We tested iSAFE performance on 22 human loci previously characterized as containing 
signatures of a selective sweep (Supplementary Note 2), with some evidence for the favored 
mutation. The list included 8 ‘well characterized’ cases with additional support for the 
favored mutation (Supplementary Table 1). Using genotype data from phase 3 of 1000 
Genomes Project (1000GP)9 sub-populations, we used iSAFE to rank all variants (∼21,000) 
in a 5 Mbp region surrounding each locus. Among the 8 well characterized cases5, 10–14 
(Fig. 3b and Supplementary Fig. 8), iSAFE ranked the candidate mutations as 1 in 5 cases: 
SLC24A5, LCT, EDAR, ACKR1, TLR1, and ranked the remaining as 2 (ABCC1), 4 (HBB), 
and 13 (G6PD).
We checked whether the other 14 loci5, 15–18 under selection showed a strong iSAFE signal 
(Supplementary Note 2). In 3 of the 14 loci (FUT2, F12, ASPM; Supplementary Fig. 9), we 
observed weak signals and did not make a prediction (peak iSAFE < 0.027). In other loci, 
iSAFE ranked the candidate mutations as 1 in the SLC45A2/MATP (CEU), MC1R (CHB
+JPT), and ATXN2-SHB3 (GBR) loci (Fig. 3c), and 7, 8, and 12 in PSCA (YRI), ADH1B 
(CHB+JPT), and PCDH15 (CHB+JPT) loci, respectively. In each case, the iSAFE-scores 
were high with the exception of PSCA (peak iSAFE = 0.04, Supplementary Fig. 9).
The other 5 putative selected loci are interesting in that the top-ranked iSAFE mutations had 
high scores, but were distinct from the reported candidate mutations (Fig. 3c; Supplementary 
Note 2). Many of these loci are involved in pigmentation, determining, skin, eye, and hair 
color. For example, the Tyrosinase (TYR) gene, encoding an enzyme involved in the first 
step of melanin production, is considered to be under positive selection with a 
nonsynonymous mutation rs1042602 as a candidate favored variant15. A second intronic 
variant, rs10831496, in GRM5, 396 kbp upstream of TYR, has been shown to have a strong 
association with skin color19. In contrast, iSAFE ranks mutation rs672144 at the top. 
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Interestingly, this variant was the top ranked mutation not only in CEU (iSAFE = 0.48, P ≪ 
1.3e-8), but also in EUR, EAS, AMR, and SAS (iSAFE > 0.5, P ≪ 1.3e-8; Supplementary 
Fig. 10). The result is consistent with a signal of selection present in all populations except 
AFR. It may not have been previously reported because it is near fixation in all populations 
of 1000GP except for AFR (Supplementary Fig. 10). We found that two distinct haplotypes 
carry the rs672144 mutation, both of which have remained at high frequency, maintained 
across a large stretch of the region, suggestive of a soft sweep with standing variation (Fig. 
3d). A similar analysis applied to loci TRPV6, KITLG, OCA-HERC2 (see Supplementary 
Note 2; Fig. 3c and Supplementary Fig. 11–13), where in each case, the top iSAFE 
mutations were identical across all non-African populations, and supported an out-of-Africa 
onset of selection. In the one remaining gene (CYP1A2/CSK; see Supplementary Note 2; 
Fig. 3c), the top ranked iSAFE mutation rs2470893 was previously found significant in a 
genome wide association study20, and was tightly linked to the candidate mutation. To 
summarize, iSAFE analysis ranked the candidate mutation among the top 13 in 14 of the 22 
loci, did not show a strong signal in 3, and identified plausible alternatives in the remaining 
5 (Supplementary Note 2).
The identification of the favored allele in a selective sweep is a long-standing problem in 
population genomics. Our results suggest that statistics obtained from the coalescent 
structure of a region under a selective sweep can indeed pinpoint the favored mutation. 
iSAFE performance remains robust to a range of simulation parameters, including initial 
frequencies (standing variation) and the frequency of the favored mutation at the time of 
sampling. While most results in the paper are presented on human populations, iSAFE can 
be easily extended to other populations as it is not highly parameterized.
ONLINE METHODS
A comprehensive explanation of the method is provided in Supplementary Note 1.
Input, output and overview.
Methods to identify signatures of selective sweeps in population genomics data have been 
actively developed3–8, 21–33, but mostly do not identify the specific mutation favored by 
selection. iSAFE uses a statistic derived solely from population genetics signals to pinpoint 
the favored mutation in a large region (5 Mbp), without having any knowledge of 
demography, specific phenotype under selection, and functional annotations of mutations. 
iSAFE uses a 2-step procedure to identify the favored variant, given a large region (5 Mbp) 
under selection. In the first step, it finds the best candidate mutations in small (low 
recombination) windows. Finally, it combines the evidence to give an iSAFE-score to all 
variants in the large region. It considers only biallelic sites, taking as input a binary SNP 
matrix with each row corresponding to a haplotype h, each column to a site e. Entries in the 
matrix correspond to the allelic state, with 0 denoting the ancestral allele, and 1 denoting the 
derived allele.
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HAF: Haplotype Allele Frequency.
A haplotype ‘contains/carries a mutation e’ if it has the derived allele at site e. Recently, we 
devised the HAF score to capture the dynamics of a selective sweep6. The HAF score for a 
haplotype h (HAF(h)) is the sum of the derived allele counts of the mutations on h (see 
Supplementary Note 1; Fig. 1a). It has been shown that, when h is a carrier of the favored 
allele, HAF(h) increases with the frequency of the favored mutation (Equation SN1.9 of 
Supplementary Note 2), in contrast to HAF scores of non-carriers (Equation SN1.10 of 
Supplementary Note 2), and this can be used to separate carrier haplotypes from non-carriers 
without knowing the favored mutation6.
SAFE: Selection of Allele Favored by Evolution.
Denote two haplotypes as ‘distinct’ if they have different HAF-scores. For any mutation e, 
let f denote the mutation frequency, or the fraction of haplotypes carrying the mutation. Let 
κ (e) (Fig. 1a) denote the fraction of distinct haplotypes that carry mutation e,
κ e = # of distinct haplotypes carrying mutation   e# of distinct haplotypes in sample   . 1
Similarly, let ϕ (e) denote the normalized sum of HAF-scores of all haplotypes carrying the 
mutation e,
ϕ e = sum of HAF‐scores of haplotypes carrying mutation   esum of HAF‐scores of all haplotypes   . 2
We observe empirically that in a region evolving according to a neutral Wright-Fisher 
model, κ (e) and ϕ (e) are both estimators of f (e) (Supplementary Fig. 1). Moreover, 
empirical results suggest that the expected value of ϕ - κ is 0, and variance is proportional to 
f (1 - f ). Based on these observations, we define the SAFE-score of mutation e as
SAFE e = ϕ − κ
f 1 − f 3
Empirically, SAFE(e) behaves like a Gaussian random variable, with mean 0, under 
neutrality (Supplementary Fig. 1), and it can be used to test departure from neutrality. 
However, its real power appears during positive selection, when SAFE-scores change in a 
dramatic, but predictable manner (Fig. 1a,b). Assuming a no recombination scenario (only 
for visual exposition), label mutations as ‘non-carrier’ if they are carried only by haplotypes 
not carrying the favored allele. The remaining mutations can be labeled as ‘ancestral’, if they 
arise before the favored mutation, or ‘descendant’, if they arise after (Fig. 1b). Representing 
each mutation as a point in a 2-dimensional plot of ϕ, κ values, these classes are clustered 
differentially (Fig. 1b). The selective sweep reduces the number of distinct haplotypes 
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carrying the favored mutation (lower κ), leaving non-carrier mutations with an increased 
fraction of distinct haplotypes (higher κ). On the other hand, increased HAF-scores in 
carrier haplotypes reduces the proportion of total HAF-score contributed by non-carrier 
haplotypes (lower ϕ). In contrast, the favored mutation has high positive value of ϕ - κ due 
to high HAF-scores for carriers (higher ϕ), and the reduced number of distinct haplotypes 
among its descendants (lower κ). As we go up to ancestral mutations, the number of non-
carrier haplotype descendants increase, and κ grows faster than ϕ. As we go down to 
descendant mutations, there is a reduction in the already small number of distinct 
haplotypes. However, ϕ decreases sharply, reducing ϕ - κ (Fig. 1a,b). Thus, we expect that 
the mutation with the highest SAFE-score is a strong candidate for the favored mutation.
We performed extensive simulations to test SAFE on samples evolving neutrally and under 
positive selection. We varied one parameter in each run (Supplementary Fig. 2), including 
window size (L = 50 kbp), number of individual haplotypes (n = 200) chosen from a larger 
effective population size (N = 20,000) scaled selection coefficient (Ns = 500), initial and 
final favored mutation frequencies (ν0 = 1/N, and ν). While standing variation, ν0 > 1/N, 
generally weakens the selection signal, the performance of SAFE remains relatively robust 
to variation in ν0. The median SAFE rank of the favored allele is at most 3 out of ∼250 
variants in all cases except when ν0 > 1000/N (Supplementary Fig. 2). Similarly, the 
performance is robust to selection pressure, with only a slight degradation at weak selection 
(Ns = 50) (Supplementary Fig. 2) where the median rank goes to 9 (3.5%-ile), while for Ns 
≥ 200 the median rank is at most 2. As expected, the performance improves with increasing 
sample size (Supplementary Fig. 2). We also tested SAFE on a model of European 
demography and observed similar results (Supplementary Fig. 2). These tests used L = 50 
kbp, chosen so as to minimize the effects of recombination.
iSAFE: integrated Selection of Allele Favored by Evolution.
Next, we tested SAFE with increasing window sizes, and observed that the median rank of 
the favored mutation increases with increasing window size (Fig. 2c). The deterioration for 
larger windows is likely due to most haplotypes becoming unique, and κ losing its utility in 
pinpointing the favored mutation. However, the selective sweep signal is known to extend to 
large, linked regions, as far as 1 Mbp on either side of the favored allele. These ‘shoulders’3 
of selective sweeps are helpful in identifying the region under selection, but make it harder 
to pinpoint the favored mutation. We further refined our method to exploit the signal from 
shoulders.
For larger regions, we considered a set of 50% overlapping windows (𝒲) of fixed size (300 
SNPs). For each window, we applied SAFE and chose the mutation with the highest SAFE-
score. Let 𝒮1 denote the set of selected mutations. Mutations in 𝒮1 are likely to contain 
either the favored mutation itself or mutations linked to it. For mutation e in window w, let 
Ψe,w’ denote the larger of the SAFE-score of e, when e is ‘inserted’ into window w’, and 0 
(Fig. 2a,b). As different windows have different genealogies due to recombination, Ψe,w’ is 
relatively high when e is the favored mutation and the genealogies of w, w’ are identical or 
very similar, but not otherwise. In contrast, the SAFE-score of a non-favored mutation e is 
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relatively low when inserted in other windows (see Supplementary Note 1; Fig. 2a). Define 
the weight of a window w as
α w =
∑
e ∈ 𝒮1
Ψe,w
∑
w′ ∈𝒲
∑
e ∈ 𝒮1
Ψe,w′
  . 4
Windows that contain the favored mutation and those sharing its genealogy are expected to 
have high α values. We defined the iSAFE-score for all mutations e (including those not in 
𝒮1) as:
iSAFE e =∑
w ∈𝒲
Ψe,w ⋅ α w   . 5
iSAFE-scores are not based upon likelihood computations, and the distribution of scores 
depend upon largely unknown factors including demography, time since onset of selection, 
selection coefficient, and other parameters. Nevertheless, they can be used to rank order the 
mutations. Additionally, iSAFE scores are normalized and can be compared across samples. 
We found distinct differences in performance below a score threshold of 0.1. The median 
rank of the favored mutation is 4 when peak iSAFE-score exceeds 0.1 versus a median rank 
of 10 along with a longer tail, when peak iSAFE-score is below 0.1 (Supplementary Fig. 7). 
Empirically computed P values on iSAFE indicate good performance when P < 1e-4 
(Supplementary Fig. 7).
Adding outgroup samples.
Not surprisingly, iSAFE performance deteriorates when the favored mutation is fixed, or 
near fixation (ν > 0.9 in Supplementary Fig. 3). To handle this special case, we include 
individuals from non-target populations. For a mutation, define the Maximum Difference in 
Derived Allele Frequency score (MDDAF) as
MDDAF = DT– min DNT 6
Where DT is the derived allele frequency in the target population and min(DNT) is the 
minimum derived allele frequency over all non-target populations. Simulations of human 
population demography under neutral evolution shows P(MDDAF > 0.78 | DT > 0.9) = 0.001 
(Supplementary Fig. 15). Therefore, when we observe the rare event of high frequency 
mutations in target (DT > 0.9) with MDDAF > 0.78, we add random outgroup samples to the 
data to constitute 10% of the data (Supplementary Note 1). In testing on the phase 3 of 
1000GP data, we chose outgroup samples from non-target 1000GP populations. The 
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addition of outgroup samples using the MDDAF criterion was tested in extensive 
simulations. While the performance did not change for ν<0.9, it dramatically improved for 
high frequencies, including when the favored mutation was fixed in the target population 
(Supplementary Fig. 3).
iSAFE evaluation.
In testing on models of human demography, we also compared against CMS. While CMS 
showed excellent performance in localizing the favored mutation, iSAFE scoring greatly 
improved the ranking. For example, iSAFE ranked the favored mutation within the top 20 in 
94% of the simulations of a 5 Mbp region (Fig. 3a and Supplementary Fig. 4), in contrast to 
CMS which had a top 20 ranking in 35% of cases.
In testing instances of previously characterized sweeps in 1000GP data, we note that 
performance is difficult to characterize due to many complicating factors. Multiple sweeps 
could be occurring in response to different selection events, including background selection 
in the same region; or polygenic selection may also dilute the selection signal at any one 
locus. Moreover, the favored mutation is well-characterized in only a few instances. We 
looked for genes/regions that showed the signature of a selective sweep in one of the 
1000GP sub-populations, and had additional evidence pointing to the favored mutation. We 
identified 22 genes with some evidence, but only 8 ‘well characterized’ cases with additional 
support for the favored mutation (see Supplementary Note 2; Supplementary Table 1).
Default simulation parameters.
Neutral and sweep samples were generated using the simulator msms34. By default, 
simulated populations are haploid with sample size of n = 200 haplotypes from a larger 
effective population of N = 20,000 haplotypes, each of length L, with default value 50 kbp 
for SAFE and 5 Mbp for iSAFE. For human populations, a mutation rate of approximately μ 
= 2.5e-8 mutations per bp per generation17, 35, and a recombination rate of approximately r 
= 1.25e-8 per bp per generation36 have been proposed. For SAFE simulations, we used a 
scaled mutation rate θ = 2Nμ = 1 mutations per kbp per generation and scaled recombination 
rate ρ = 2Nr = 0.5 crossovers per kbp per meosis to approximate human rates. The rates 
were scaled linearly by L. In the case of positive selection the default scaled selection 
strength of the favored allele was set to Ns = 500, with the favored mutation located at a 
random position uniformly distributed on the range [1, L]. The default value for favored 
mutation starting frequency ν0 = 1/N (hard sweep), and the frequency of the favored 
mutation (ν) at the time of sampling is a random value uniformly distributed on the range 
[0.1, 0.9]. We used the default parameters for all simulations unless otherwise stated.
A model of human demography.
We simulated demography of AFR, EUR, EAS populations with parameter shown in the 
Supplementary Fig. 14 based on a popular demographic model of human population37. In 
case of positive selection, selection coefficient was set to s = 0.05 and starting favored allele 
frequency ν0 = 0.001. The time of onset of selection was chosen at random (using the 
distribution in Supplementary Fig. 14) after the out of Africa event, in the lineage of EUR 
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population (as the target population). When the onset of selection is before split of EUR and 
EAS (> 23kya), both (EUR and EAS) are under selection.
Computing iHS scores.
We used the selscan38 (v1.1.0a) software available at https://github.com/szpiech/selscan, 
with default settings to calculate the raw iHS8 score. Next, we normalized the iHS score by 
estimating the distribution of raw iHS scores on 1,000 neutral simulations with the same 
simulation parameters. The iHS scores were always computed on a 5 Mbp window. When 
comparing results with SAFE on a 50 kbp window, we used the corresponding iHS scores in 
the identical 50 kbp region surrounding the favored variant (Fig. 1c and Supplementary 
Figure 2). In considering 5 Mbp windows (Supplementary Figure 3), we compared the iHS 
scores on all variants for iHS against iSAFE.
Computing SCCT scores.
We used the SCCT (v1.1) software available at https://github.com/wavefancy/scct, provided 
by Wang et al. (2014)7, with flanking SNPs size 300, and frequency interval 0.01.
Computing CMS scores.
CMS5 requires a control population as well as a demographic model in addition to the target 
population under selection. All CMS comparisons on simulated data were performed using a 
model of human demography37 with a random onset of selection (Supplementary Figure 
14). We used the CMS (v2.0) software available at https://github.com/broadinstitute/cms, 
disabling CMS’ default allele frequency filter in order to allow a more direct comparison 
with iSAFE SNP ranking.
Computing empirical P value.
We applied iSAFE on a neutrally evolving simulated population with window size 5 Mbp, 
based on European demography shown in Supplementary Figure 14. A P value was 
calculated based on empirical distribution of iSAFE on these simulated populations. We 
limited the number of samples to ~74,800,000 for efficiency, and this allows us to get a P 
value as low as 1.34e-8 for iSAFE = 0.304. Scores higher than this cut-off are considered to 
have P < 1.34e-8.
Putative selective sweeps in human populations.
We examined 8 well characterized selective sweeps with strong candidate mutation. These 
genes are LCT, SLC24A5, TLR1, EDAR, ACKR1/DARC, ABCC11, HBB, and G6PD. 
iSAFE results for these genes are summarized in Fig. 3b, Supplementary Fig. 8 and 
Supplementary Table 1. We also examined 14 other regions reported to be under selection 
with one or more candidate favored mutations. A detailed report for each of these 14 loci is 
provided in Supplementary Note 2.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Illustration and performance of the SAFE method. (a) The HAF score for haplotype h is the 
sum of the derived allele counts of the mutations on h. Carriers of the favored mutation have 
higher fraction of the total HAF score of the sample (high ϕ)6, and lower number of distinct 
haplotypes compared to non-carriers (low κ). (b) Schematic of a no-recombination (for 
exposition purposes) genealogy under a selective sweep. The mutations can be categorized 
as ‘non-carrier’ (gray), ‘ancestral to favored’ (turquoise) arising prior to the favored 
mutation, and ‘descendant to favored’ (blue) that arise on haplotypes carrying the favored 
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mutations but after the favored mutation, and the favored mutation itself (red). In the right 
panels, simulations showing ϕ versus κ values for each variant in a neutral evolution and a 
selective sweep for 1000 simulations with favored allele frequency (ν0 = 0.5) and default 
values for other simulation parameters (see Online Methods). The joint-distribution of ϕ and 
κ, in a selective sweep, changes in a dramatic but predictable manner that separates out non-
carrier (gray), descendant (blue), and ancestral (turquoise) mutations from the favored (red) 
mutations. The SAFE score computes a normalized difference of the two statistics, ϕ and κ. 
(c) Performance (favored mutation rank) of SAFE compared to iHS and SCCT on 50 kbp 
windows with 1000 simulations per frequency bin. The simulations were performed with 
default parameter values (see Online Methods) for a fixed population size with ongoing 
selective sweeps. The left panel combines all allele frequencies while the right panel shows 
median and mean ranks for replicates divided into four bins.
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Figure 2. 
Illustration of the iSAFE method. (a) The red-star, turquoise-triangle, and blue-square 
denote the favored, ancestral, and descendant mutations, respectively. As different windows 
have different genealogies due to recombination, the SAFE-score of a non-favored mutation 
e is relatively low when inserted in other windows. In contrast, the SAFE-score of the 
favored mutation is likely to dominate other mutations (Supplementary Note 1). (b) The 
Ψe,w matrix for a 5 Mbp region around LCT gene in FIN population shows that the 
‘shoulder’ of selection can extend for a few Mbp. The blue circle shows the location of the 
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putative favored mutation rs4988235. (c) SAFE and iSAFE performance (rank distribution 
of favored mutation) as a function of window size with 1000 simulations per bin. The dashed 
(dotted) line represents median (quartile), and decays for large windows while iSAFE is 
robust to increase in window size.
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Figure 3. 
iSAFE performance. (a) The top left (right) panel is the Cumulative Distribution Function 
(CDF) of favored mutation rank (peak distance) for iSAFE and CMS scores. The lower 
panel shows the iSAFE performance (rank and peak distance distributions of favored 
mutation) as a function of favored allele frequency (ν ) in the target population (EUR). The 
dashed (dotted) line represents median (quartiles). All data is based on 1000 simulations of 5 
Mbp genomic regions simulated using a model of human genome based on the human 
demography (Supplementary Fig. 14). The time of onset of selection was chosen at random 
(using the distribution in Supplementary Fig. 14) after the out of Africa event, in the lineage 
of EUR population (as the target population). When the onset of selection is before split of 
EUR and EAS (>23kya), both (EUR and EAS) are under selection. (b) iSAFE and CMS 
scores (top and bottom panels, respectively) on 4 well-characterized selective sweeps 
(Supplementary Fig 8; Supplementary Table 1). The rank of the putative favored mutation 
(red star) in 5 Mbp region is shown in top left corner. (c) iSAFE-scores on regions under 
selection. Top ranked iSAFE candidates are marked by blue squares when they match 
putative favored mutations, while turquoise circles represent new favored mutations 
suggested by iSAFE. All data-sets were chosen by taking a 5 Mbp window around the 
putative selected region, unless one side reached the telomere or centromere. (d) The 
GRM5-TYR region. The mutation rs672144 is ranked first by iSAFE and very well 
separated from rest of the mutations in 5 Mbp around it, in all non-African populations with 
high confidence (iSAFE > 0.5, P ≪ 1.3e-8; Supplementary Fig. 10). The upper panel is 
haplotype plot with core mutation rs672144 on all 5008 haplotypes (2504 samples) of 
1000GP. This plot shows carrier haplotypes of mutation rs672144 are conserved over a 
longer span than haplotypes in non-carriers which is a signal of selection8. Lower panel 
shows global frequencies of carrier haplotypes of mutation rs672144 (red, blue) and non-
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carrier haplotypes (gray). The evidence is consistent with an out of Africa selection on 
standing variation (soft sweep) with mutation rs672144 as the favored variant.
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